I find this chart to be quite remarkable and interesting. I love using chats to reflect back on history and time to see what happened, where we were and now how far we come. This chart is a perfect example of that.
What I have here is a chart of the VIX or the Volatility Index. I have it set to a weekly chart and what I am doing is just mapping out a few key...
LT Price Target - $320 (Mid December)
ST Price Target - $220 (Early November)
Boeing took a hard hit post Covid market crash and is ready to turn to the upside after its earnings report the 27th.
Looking to enter November for a strong push towards the $320 mark.
Chart seems to have broken out of a bullish wedge pattern, bouncing off of its resistance trend...
On Thursday, the stock formed Gravestone doji with high volumes.
But on the last day, the bears have been negated since fresh demand has come into place at the POC.
Good price to enter, with stop loss as the red line.
Posted weekly chart for clearer long term view, but Pfizer bounced nicely off 21EMA / Trend line support and supply zone so far.
Want to see follow through and a reversal now with higher lows to confirm further move to the upside.
Last add to 10/15 calls
Informed Players and speculators at Sub $100 levels are booking gains
we wait for additional drwadowns and re accomodation ACCUMULATION of designated Bankers for the next run up OR cycle
Vaccine COViD was intense HiV was the sell on News..
we await next Drama and Biden Policy on Healthcare etc..
for now Watch or Chrun at key leves (eyeball the box)
Pfizer appears to have completed retracement from high's , found support on 100EMA cloud and indicating a change in momentum for a possible nice swing trade.
Optimal buy zone would be black trend line but I'm going with starter $45 10/15Cs here. Will add if it continues to dip up until 43 stop loss.
Edesa Biotech Inc (NASDAQ: EDSA) is surging higher Monday after the company announced positive Phase 2 data of its monoclonal antibody in hospitalized COVID-19 patients. Critically ill patients demonstrated a 68.5% reduction in the risk of dying when treated with EB05 over standard of care.
An independent Data and Safety Monitoring Board concluded that "a...
***Yen is higher time frame bearish due to the way its central banking has set up its infrastructure***
that is all, will conduct regular weekly reviews and outlook. just wanted to jot down a refresher for myself as a mfer is busy af hope this helps anyone but you will need to be knowledgeable on:
- intraday time frames
- candle body closures
- fundamental data...
Tradingview has some amazing data on COVID. This chart is of importance for long term investment purposes (see fat disclaimer below).
Importantly this is about total of all cases infections and deaths. Some may say that's meaningless. But there are important features on the chart.
Say what you see! I'll say what I see.
If the war on COVID was being won, one...
Singapore just made the USA travel advisory list... and we have not yet even open borders.
SG just need to first get its house in order, then dreams will work out.
Anyways, I was having a chat about the astronomical numbers (by SG standards) and we looked at the charts. Then we projected where there might be peaking out. Knowing full well that in Indonesia and...
Still swinging Pfizer calls. Bullish divergence on RSI indicator 1HR
Still holding longer term uptrend.
Mid October - NOV 45Cs as an idea or credit spread 45/40P
Break below black line invalidates trade idea
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS) shares jumped 135.4% to settle at $5.32 on Friday. The stock possibly traded higher following favorable data results by AstraZeneca for patients with unresectable, stage 3 non-small cell lung cancer.
Corvus Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, focuses on the development and...
Q: What has the highest probability of occurring?
After being one of the strongest performers in 2020 during the initial UK lockdown the stock lost over 30% of its value.
In 2021 it has staged a modest recovery but is still over 15% below its all time high requiring an over 20% rally.
There is well tested support at 8100p and resistance at 8775p.
There is 2...
TESLA. The fast stock and the fast to drop. Tesla is about the drop with everything else.
Tesla is not worth the current value and the value is pushed because of the moneyflow from state not sales.
Keep that in mind.
